Fundraising FoxHistide
Schindellegi, CH · 2 known investors
Find your way into Histide
Sign up to see every warm intro you have to Histide
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Histide team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Histide is a biotech intellectual property platform company developing a class of non-mutagenic extracellular therapeutic agents called Cell Recoding Molecules (CRM), which act on the cell's microenvironment to redirect cell fate for tissue regeneration and disease treatment. Its Recoding Therapeutics platform targets applications across pharmaceuticals, medical devices, and medical cosmetics, with a pipeline spanning five strategic therapeutic areas.
Investors · 2
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountseries ANov 2014
PARTER Capital Group AG (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Histide do?
- Histide is a biotech intellectual property platform company developing a class of non-mutagenic extracellular therapeutic agents called Cell Recoding Molecules (CRM), which act on the cell's microenvironment to redirect cell fate for tissue regeneration and disease treatment. Its Recoding Therapeutics platform targets applications across pharmaceuticals, medical devices, and medical cosmetics, with a pipeline spanning five strategic therapeutic areas.
- Who are Histide's investors?
- Histide's investors include Open Field Capital.
- Where is Histide headquartered?
- Histide is headquartered in Schindellegi, CH.